On the recordFebruary 24, 2016
I want to get to the real crux of the problem here, because I think we are confusing the approval rate versus the ability of a patient like Matt to actually get a drug and have the 'Right to Try.'
Source
congress.govEditor's note · Context
Ron Johnson emphasizes the need to focus on patient access to drugs, not just approval rates.
Share
More from Ron Johnson
Aug 11, 2026
We tell pregnant women don't even have a glass of wine and yet we coerce them, convince them, sometimes mandated them, to get an experimental gene therapy as early as the first trimester.
Jul 23, 2025
I want the press to be honest. I want Pulitzer Prizes to be returned. They were either duped or complicit in pushing that false narrative that put America in political turmoil for years.
May 27, 2026
My bipartisan nominating commission with Sen. Baldwin submitted two well-qualified U.S. attorneys for the President’s consideration.
Aug 7, 2026
We’re not giving up. I mean, we need to fund [the] military, I believe. We need to fund election integrity measures. So, I can’t predict the future.
Other voices in this conversation
